Firazyr
NIH Scientists Discover Molecule Triggers Sensation of Itch »
"Scientists at the National Institutes of Health report they have discovered in mouse studies that a small molecule released in the spinal cord triggers a process that is later experienced in the brain as the sensation of itch.
The small"...
Read the NIH Scientists Discover Molecule Triggers Sensation of Itch article »
Firazyr
OVERDOSE
In a clinical study evaluating a 90 mg dose (30 mg in each of 3 subcutaneous sites), the adverse event profile was similar to that seen with 30 mg administered in a single subcutaneous site.
In another clinical study, a dose of 3.2 mg/kg administered intravenously (approximately 8 times the therapeutic dose for HAE) caused erythema, itching and hypotension in healthy subjects. No therapeutic intervention was necessary.
CONTRAINDICATIONS
None.
Last reviewed on RxList: 9/1/2011
This monograph has been modified to include the generic and brand name in many instances.
Additional Firazyr Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Women's Health
Find out what women really need.
Updated & New
